We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+11.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.37B
AUM Growth
+$369M
(+12%)
Cap. Flow
+$44.9M
Cap. Flow
% of AUM
1.33%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
3,551
New
186
Increased
1,137
Reduced
1,414
Closed
232
Avg Time Held Equity + Options
4
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.7
years
Avg Time Held Equity only
4
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$174M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$19M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$18.8M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$8.59M |
| 5 |
iShares Global Tech ETF
IXN
|
+$2.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$69.6M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$31.6M |
| 3 |
Okta
OKTA
|
+$21.1M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$14.3M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.92% |
| 2 | Technology | 14.72% |
| 3 | Healthcare | 9.12% |
| 4 | Financials | 6.99% |
| 5 | Consumer Discretionary | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2021 Q1
11 quarters
|
|
|
AAGR
3252
DELISTED
African Agriculture Holdings Inc
AAGR
| $38 | ﹤0.01% |
30
+1
| +3% | +$5 |
2022 Q1
7 quarters
|
|
3253
Solid Biosciences
SLDB
$615M
| $37 | ﹤0.01% |
6
| – | – |
2022 Q1
7 quarters
|
|
3254
Corvus Pharmaceuticals
CRVS
$829M
| $35 | ﹤0.01% |
20
| – | – |
2021 Q2
10 quarters
|
|
3255
Americas Gold and Silver
USAS
$1.31B
| $33 | ﹤0.01% |
52
| – | – |
2022 Q1
7 quarters
|
|
3256
Rigetti Computing
RGTI
$4.22B
| $30 | ﹤0.01% |
30
| – | – |
2021 Q4
8 quarters
|
|
3257
Alzamend Neuro
ALZN
$6.18M
| – | – |
0
| – | – |
2023 Q4
0 quarters
|
|
3258
Foremost Lithium Resource & Technology
FMST
$9.2M
| $25 | ﹤0.01% |
10
-1,250
| -99% | -$4.1K |
2023 Q3
1 quarter
|
|
3259
OmniAb
OABI
$688M
| $25 | ﹤0.01% |
4
| – | – |
2022 Q4
4 quarters
|
|
3260
DELISTED
Akoustis Technologies Inc
AKTS
| $25 | ﹤0.01% |
30
| – | – |
2020 Q4
12 quarters
|
|
|
RNLX
3261
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $23 | ﹤0.01% |
+60
| New | +$48 |
2023 Q4
0 quarters
|
|
3262
Spyre Therapeutics
SYRE
$7.49B
| $22 | ﹤0.01% |
+1
| New | +$14 |
2023 Q4
0 quarters
|
|
3263
Recursion Pharmaceuticals
RXRX
$2.23B
| $20 | ﹤0.01% |
2
-63
| -97% | -$449 |
2023 Q2
2 quarters
|
|
3264
State Street SPDR S&P Bank ETF
KBE
$1.48B
| – | – |
0
| – | – |
2023 Q3
1 quarter
|
|
3265
DELISTED
Doma Holdings, Inc.
DOMA
| $19 | ﹤0.01% |
4
| – | – |
2021 Q3
9 quarters
|
|
|
NAVB
3266
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $19 | ﹤0.01% |
350
| – | – |
2020 Q1
15 quarters
|
|
3267
Energous
WATT
$49.5M
| – | – |
0
| – | – |
2021 Q2
10 quarters
|
|
3268
Ellsworth Growth & Income Fund
ECF
$161M
| $17 | ﹤0.01% |
2
| – | – |
2021 Q1
11 quarters
|
|
3269
AMC Entertainment Holdings
AMC
$2.7B
| $12 | ﹤0.01% |
+2
| New | +$16 |
2023 Q4
0 quarters
|
|
3270
Hyliion Holdings
HYLN
$586M
| $12 | ﹤0.01% |
14
| – | – |
2020 Q3
13 quarters
|
|
3271
Clean Energy Fuels
CLNE
$333M
| $11 | ﹤0.01% |
3
| – | – |
2020 Q4
12 quarters
|
|
3272
DELISTED
Enhabit
EHAB
| $10 | ﹤0.01% |
1
-96
| -99% | -$907 |
2022 Q3
5 quarters
|
|
3273
Hornbeck Offshore Services, Inc.
HOS
$2.2B
| $10 | ﹤0.01% |
1
| – | – |
2021 Q2
10 quarters
|
|
3274
State Street SPDR S&P Global Dividend ETF
WDIV
$278M
| – | – |
-49
| Closed | -$2.75K | – |
|
3275
Western Copper and Gold
WRN
$414M
| $8 | ﹤0.01% |
6
| – | – |
2016 Q4
28 quarters
|
|
Similar funds
Parallel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Parallel Advisors held 3,551 positions worth $3.37B, up 12% from $3B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q4 2023 filing shows 186 new, 1,137 increased, 1,414 reduced and 232 closed positions. Its largest new stake was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M. The largest sale was Schwab US Dividend Equity ETF, an estimated $69.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q4 2023 buy was PIMCO Multi Sector Bond Active ETF: 62,879 shares worth $1.61M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $174M increase.
- Parallel Advisors's biggest Q4 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $69.6M.
- Parallel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $591K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.37B portfolio in Q4 2023.
- Parallel Advisors opened 186 new positions and closed 232 in Q4 2023.
- Parallel Advisors's portfolio value rose 12% quarter-over-quarter to $3.37B.
Based on Parallel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.